SE0200730L - Kristallin bas av citalopram - Google Patents

Kristallin bas av citalopram

Info

Publication number: SE0200730L
Authority: SE; Sweden
Prior art keywords: citalopram; base; salt; crystalline; precipitation
Prior art date: 2000-03-13

Application number

SE0200730A

Other languages

English (en)

Other versions

SE526022C2 (sv

SE0200730D0 (sv

Inventor

Hans Petersen

Klaus Peter Boegesoe

Per Holm

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-13

Filing date

2002-03-12

Publication date

2002-08-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0200730(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-12 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2002-03-12 Publication of SE0200730D0 publication Critical patent/SE0200730D0/sv

2002-08-29 Publication of SE0200730L publication Critical patent/SE0200730L/sv

2005-06-14 Publication of SE526022C2 publication Critical patent/SE526022C2/sv

Links

WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 title abstract 9
229960001653 citalopram Drugs 0.000 title abstract 6
238000006243 chemical reaction Methods 0.000 abstract 2
238000004519 manufacturing process Methods 0.000 abstract 2
238000001556 precipitation Methods 0.000 abstract 2
238000001953 recrystallisation Methods 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 abstract 1
XAJMJYPAJNLKIS-UHFFFAOYSA-N [5-(4-bromophenyl)furan-2-yl]methanamine Chemical compound O1C(CN)=CC=C1C1=CC=C(Br)C=C1 XAJMJYPAJNLKIS-UHFFFAOYSA-N 0.000 abstract 1
125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
239000012535 impurity Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229940126570 serotonin reuptake inhibitor Drugs 0.000 abstract 1
125000003107 substituted aryl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Laminated Bodies (AREA)
Compositions Of Macromolecular Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Silicates, Zeolites, And Molecular Sieves (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Manufacture Of Macromolecular Shaped Articles (AREA)
Plural Heterocyclic Compounds (AREA)

SE0200730A 2000-03-13 2002-03-12 Kristallin bas av citalopram SE526022C2 (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200000402		2000-03-13

Publications (3)

Publication Number	Publication Date
SE0200730D0 SE0200730D0 (sv)	2002-03-12
SE0200730L true SE0200730L (sv)	2002-08-29
SE526022C2 SE526022C2 (sv)	2005-06-14

Family

ID=8159320

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SE0103046A SE517136C2 (sv)	2000-03-13	2001-09-14	Kristallin bas av citalopram
SE0200730A SE526022C2 (sv)	2000-03-13	2002-03-12	Kristallin bas av citalopram

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SE0103046A SE517136C2 (sv)	2000-03-13	2001-09-14	Kristallin bas av citalopram

Country Status (41)

Country	Link
US (7)	US20010031784A1 (sv)
EP (2)	EP1169314B2 (sv)
JP (1)	JP2003527383A (sv)
KR (1)	KR20020080486A (sv)
CN (2)	CN1680350A (sv)
AR (1)	AR029811A1 (sv)
AT (3)	ATE223396T1 (sv)
AU (2)	AU746664B2 (sv)
BE (1)	BE1013210A3 (sv)
BG (1)	BG107065A (sv)
BR (1)	BR0109373A (sv)
CA (2)	CA2411732A1 (sv)
CH (2)	CH691477A5 (sv)
CZ (1)	CZ292077B6 (sv)
DE (7)	DE20007303U1 (sv)
DK (3)	DK173903B1 (sv)
EA (1)	EA200200972A1 (sv)
ES (3)	ES2180471T3 (sv)
FI (2)	FI20010156A0 (sv)
FR (1)	FR2806086B1 (sv)
GB (2)	GB2357762B (sv)
GR (1)	GR1003796B (sv)
HR (1)	HRP20020756A2 (sv)
HU (3)	HU0001581D0 (sv)
IE (1)	IES20010109A2 (sv)
IL (2)	IL147339A (sv)
IS (1)	IS5841A (sv)
IT (2)	IT1319645B1 (sv)
MX (1)	MXPA02008793A (sv)
NL (2)	NL1016435C1 (sv)
NO (2)	NO312031B1 (sv)
PL (1)	PL360158A1 (sv)
PT (2)	PT1227088E (sv)
SE (2)	SE517136C2 (sv)
SI (2)	SI1169314T2 (sv)
SK (1)	SK285528B6 (sv)
TR (1)	TR200202185T2 (sv)
UA (1)	UA74360C2 (sv)
WO (1)	WO2001068627A1 (sv)
YU (1)	YU68802A (sv)
ZA (1)	ZA200207148B (sv)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL145615A0 (en) *	1999-04-14	2002-06-30	Lundbeck & Co As H	Method for the preparation of citalopram
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
US7887556B2 (en)	2000-12-20	2011-02-15	Fox Hollow Technologies, Inc.	Debulking catheters and methods
US7713279B2 (en)	2000-12-20	2010-05-11	Fox Hollow Technologies, Inc.	Method and devices for cutting tissue
US7708749B2 (en)	2000-12-20	2010-05-04	Fox Hollow Technologies, Inc.	Debulking catheters and methods
US8328829B2 (en)	1999-08-19	2012-12-11	Covidien Lp	High capacity debulking catheter with razor edge cutting window
US6299622B1 (en)	1999-08-19	2001-10-09	Fox Hollow Technologies, Inc.	Atherectomy catheter with aligned imager
IES20010157A2 (en)	2000-03-03	2002-03-06	Lundbeck & Co As H	Method for the preparation of citalopram
NL1017500C1 (nl)	2000-03-13	2001-04-26	Lundbeck & Co As H	Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en)	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es)	2000-05-12	2003-11-12	Lundbeck & Co As H	Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2353693C (en) *	2000-08-10	2003-07-22	H. Lundbeck A/S	Pharmaceutical composition containing citalopram
GB2376233B (en) *	2000-08-10	2003-09-10	Lundbeck & Co As H	Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
JP4080874B2 (ja)	2000-12-20	2008-04-23	フォックスハロウテクノロジーズ，インコーポレイティド	減嵩カテーテル
TR200201166T1 (tr) *	2000-12-22	2002-10-21	H.Lundbecks A/S	Saf sitalopram hazırlanması için yöntem
AU2001100195B4 (en) *	2001-01-05	2001-12-20	H Lundbeck As	Pharmaceutical composition containing citalopram.
GB0105627D0 (en) *	2001-03-07	2001-04-25	Cipla Ltd	Preparation of phthalanes
CA2445843A1 (en) *	2001-05-01	2002-11-07	H. Lundbeck A/S	The use of enantiomeric pure escitalopram
ATE352546T1 (de)	2001-07-31	2007-02-15	Lundbeck & Co As H	Kristalline zusammensetzung enthaltend escitalopram
WO2003057132A2 (en) *	2002-01-07	2003-07-17	Sun Pharmaceutical Industries Limited	Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2386118A (en) *	2002-02-27	2003-09-10	Cipla Ltd	Citalopram
GB2385848A (en) *	2002-02-27	2003-09-03	Cipla Ltd	Citalopram salts
GB2387844B (en) *	2002-02-27	2005-05-11	Matrix Lab Ltd	Separation of impurities from a crude mixture of citalopram
GB0204607D0 (en)	2002-02-27	2002-04-10	Matrix Lab Ltd	Process
GB2386119A (en) *	2002-02-27	2003-09-10	Cipla Ltd	Purification of citalopram
EP1346989A1 (en) *	2002-03-21	2003-09-24	Jubilant Organosys Limited	Improved process for the preparation of citalopram and its hydrobromide
GB0206708D0 (en) *	2002-03-21	2002-05-01	Cipla Ltd	Pharmaceutical salts
US6812355B2 (en)	2002-10-22	2004-11-02	Sekhsaria Chemicals Limited	Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
AU2003223105A1 (en) *	2003-03-24	2004-10-18	Hetero Drugs Limited	Novel crystalline forms of (s)-citalopram oxalate
WO2004094399A1 (en) *	2003-04-21	2004-11-04	Natco Pharma Ltd	An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en)	2003-04-22	2012-08-21	Tyco Healthcare Group Lp	Methods and devices for cutting tissue at a vascular location
EP1486492A3 (en) *	2003-06-10	2005-02-23	Sun Pharmaceuticals Industries Ltd.	A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
GB0317475D0 (en) *	2003-07-25	2003-08-27	Meditab Specialities Pvt Ltd	Product
JP4025735B2 (ja) *	2003-08-21	2007-12-26	ロームアンドハースカンパニー	水性系を処理する方法
GB0320312D0 (en)	2003-08-29	2003-10-01	Novartis Ag	Purification process
CN100569765C (zh)	2003-12-19	2009-12-16	杭州民生药业集团有限公司	西酞普兰中间体晶体碱
ITTO20050301A1 (it) *	2005-05-05	2006-11-06	Errekappa Euroterapici Spa	Formulazioni liquide orali contenenti citalopram
US20110196032A1 (en) *	2005-05-20	2011-08-11	Ashish Gogia	Pharmaceutical Dosage Form of an Antidepressant
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) *	2005-06-22	2012-02-21	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersibl
US7241805B2 (en)	2005-06-27	2007-07-10	Biovail Laboratories, Inc.	Modified release formulations of a bupropion salt
US20070276419A1 (en)	2006-05-26	2007-11-29	Fox Hollow Technologies, Inc.	Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en)	2008-02-25	2014-07-22	Covidien Lp	Methods and devices for cutting tissue
EP3275383A1 (en)	2008-10-13	2018-01-31	Covidien LP	Devices and methods for manipulating a catheter shaft
AU2010241801B2 (en)	2009-04-29	2013-04-11	Covidien Lp	Methods and devices for cutting and abrading tissue
JP5281195B2 (ja)	2009-05-14	2013-09-04	コヴィディエンリミテッドパートナーシップ	簡単に清掃され得るアテレクトミー用カテーテルおよび使用の方法
BR112012013389A2 (pt)	2009-12-02	2018-03-06	Tyco Healthcare	métodos e dispositivos para o corte de um tecido
KR101398384B1 (ko)	2009-12-11	2014-05-23	코비디엔 엘피	물질 포획 효율이 향상된 물질 제거 장치 및 사용 방법
US9119662B2 (en)	2010-06-14	2015-09-01	Covidien Lp	Material removal device and method of use
CN103200886B (zh)	2010-10-28	2015-07-29	科维蒂恩有限合伙公司	物质移除装置和使用方法
BR112013011632A2 (pt)	2010-11-11	2016-08-09	Covidien Lp	cateteres de citorredução flexíveis com imagiologia e métodos de uso e fabricação
WO2013033426A2 (en)	2011-09-01	2013-03-07	Covidien Lp	Catheter with helical drive shaft and methods of manufacture
US9579157B2 (en)	2012-09-13	2017-02-28	Covidien Lp	Cleaning device for medical instrument and method of use
US9943329B2 (en)	2012-11-08	2018-04-17	Covidien Lp	Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en)	2014-06-27	2015-12-30	Covidien Lp	Cleaning device for catheter and catheter including the same
US10314667B2 (en)	2015-03-25	2019-06-11	Covidien Lp	Cleaning device for cleaning medical instrument
US10292721B2 (en)	2015-07-20	2019-05-21	Covidien Lp	Tissue-removing catheter including movable distal tip
US10314664B2 (en)	2015-10-07	2019-06-11	Covidien Lp	Tissue-removing catheter and tissue-removing element with depth stop
EP3999058A4 (en)	2019-07-19	2023-05-03	Bioxcel Therapeutics, Inc.	TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN
US11806334B1 (en)	2023-01-12	2023-11-07	Bioxcel Therapeutics, Inc.	Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2233970A (en) *		1941-03-04		Quinoline compound and process of
US2584429A (en) *	1950-12-29	1952-02-05	Rohm & Haas	1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143703A (sv) *	1965-03-18
US4314081A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Arloxyphenylpropylamines
GB1526331A (en)	1976-01-14	1978-09-27	Kefalas As	Phthalanes
IL63968A (en) *	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) *	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
DK213290D0 (da)	1990-09-06	1990-09-06	Lundbeck & Co As H	Treatment of cerebrovascular disorders
CA2120874E (en) *	1994-04-08	2002-01-08	Keshava Murthy	Form of form 1 ranitidine
JP3526581B2 (ja) *	1997-07-08	2004-05-17	ハー・ルンドベック・アクティーゼルスカブ	シタロプラムの製造方法
UA62985C2 (en) *	1997-11-10	2004-01-15	Lunnbeck As H	A method for the preparation of citalopram
CN1286687A (zh) *	1997-11-11	2001-03-07	H·隆德贝克有限公司	制备西酞普兰的方法
WO2000023431A1 (en) *	1998-10-20	2000-04-27	H. Lundbeck A/S	Method for the preparation of citalopram
IL145615A0 (en)	1999-04-14	2002-06-30	Lundbeck & Co As H	Method for the preparation of citalopram
ITMI991581A1 (it) *	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
ITMI991579A1 (it) *	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
US6433196B1 (en) *	2000-02-17	2002-08-13	Sumika Fine Chemicals Co., Ltd.	Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en) *	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof

2000
- 2000-04-13 GB GB0105982A patent/GB2357762B/en not_active Expired - Fee Related
- 2000-04-18 HU HU0001581A patent/HU0001581D0/hu unknown
- 2000-04-20 DE DE20007303U patent/DE20007303U1/de not_active Ceased
- 2000-10-18 NL NL1016435A patent/NL1016435C1/nl not_active IP Right Cessation
- 2000-11-09 IT IT2000MI002425A patent/IT1319645B1/it active
- 2000-12-05 US US09/730,490 patent/US20010031784A1/en not_active Abandoned
2001
- 2001-01-25 FI FI20010156A patent/FI20010156A0/sv unknown
- 2001-01-26 HU HU0100450A patent/HU0100450D0/hu unknown
- 2001-02-05 DK DK200100183A patent/DK173903B1/da not_active IP Right Cessation
- 2001-02-05 IS IS5841A patent/IS5841A/is unknown
- 2001-02-05 HU HU0100531A patent/HUP0100531A3/hu unknown
- 2001-02-05 GB GBGB0102797.8A patent/GB0102797D0/en not_active Ceased
- 2001-02-06 NO NO20010619A patent/NO312031B1/no active IP Right Review Request
- 2001-02-07 FI FI20010225A patent/FI109022B/sv active
- 2001-02-07 IE IE20010109A patent/IES20010109A2/en not_active IP Right Cessation
- 2001-02-12 GR GR20010100074A patent/GR1003796B/el unknown
- 2001-02-20 DE DE20121240U patent/DE20121240U1/de not_active Ceased
- 2001-02-20 DE DE10108042A patent/DE10108042A1/de not_active Withdrawn
- 2001-02-20 DE DE10164687A patent/DE10164687B4/de not_active Revoked
- 2001-02-21 FR FR0102340A patent/FR2806086B1/fr not_active Expired - Fee Related
- 2001-02-21 NL NL1017413A patent/NL1017413C1/nl not_active IP Right Cessation
- 2001-02-22 CH CH00321/01A patent/CH691477A5/de not_active IP Right Cessation
- 2001-02-22 CH CH00580/01A patent/CH691537A5/de not_active IP Right Cessation
- 2001-02-28 CN CNA2005100091603A patent/CN1680350A/zh active Pending
- 2001-02-28 KR KR1020027012048A patent/KR20020080486A/ko not_active Ceased
- 2001-02-28 DK DK01909568T patent/DK1169314T3/da active
- 2001-02-28 AT AT01909568T patent/ATE223396T1/de not_active IP Right Cessation
- 2001-02-28 IL IL14733901A patent/IL147339A/en not_active IP Right Cessation
- 2001-02-28 CA CA002411732A patent/CA2411732A1/en not_active Abandoned
- 2001-02-28 DE DE60100786T patent/DE60100786T2/de not_active Revoked
- 2001-02-28 IL IL15807201A patent/IL158072A0/xx unknown
- 2001-02-28 JP JP2001567719A patent/JP2003527383A/ja active Pending
- 2001-02-28 AR ARP010100934A patent/AR029811A1/es unknown
- 2001-02-28 DE DE1227088T patent/DE1227088T1/de active Pending
- 2001-02-28 HR HRP20020756 patent/HRP20020756A2/hr not_active Application Discontinuation
- 2001-02-28 WO PCT/DK2001/000137 patent/WO2001068627A1/en not_active Ceased
- 2001-02-28 MX MXPA02008793A patent/MXPA02008793A/es active IP Right Grant
- 2001-02-28 BR BR0109373-8A patent/BR0109373A/pt not_active IP Right Cessation
- 2001-02-28 TR TR2002/02185T patent/TR200202185T2/xx unknown
- 2001-02-28 ES ES02009350T patent/ES2180471T3/es not_active Expired - Lifetime
- 2001-02-28 PT PT02009350T patent/PT1227088E/pt unknown
- 2001-02-28 EP EP01909568A patent/EP1169314B2/en not_active Expired - Lifetime
- 2001-02-28 BE BE2001/0136A patent/BE1013210A3/fr not_active IP Right Cessation
- 2001-02-28 PL PL36015801A patent/PL360158A1/xx not_active Application Discontinuation
- 2001-02-28 EA EA200200972A patent/EA200200972A1/ru unknown
- 2001-02-28 DK DK02009350T patent/DK1227088T3/da active
- 2001-02-28 SI SI200130001T patent/SI1169314T2/sl unknown
- 2001-02-28 PT PT01909568T patent/PT1169314E/pt unknown
- 2001-02-28 UA UA2002097314A patent/UA74360C2/uk unknown
- 2001-02-28 CN CNB018093418A patent/CN1258530C/zh not_active Expired - Fee Related
- 2001-02-28 AU AU37252/01A patent/AU746664B2/en not_active Ceased
- 2001-02-28 SI SI200130031T patent/SI1227088T1/xx unknown
- 2001-02-28 SK SK1313-2002A patent/SK285528B6/sk unknown
- 2001-02-28 EP EP02009350A patent/EP1227088B1/en not_active Revoked
- 2001-02-28 CA CA002360287A patent/CA2360287C/en not_active Expired - Lifetime
- 2001-02-28 ES ES01909568T patent/ES2173054T3/es not_active Expired - Lifetime
- 2001-02-28 AT AT02009350T patent/ATE250050T1/de not_active IP Right Cessation
- 2001-02-28 YU YU68802A patent/YU68802A/sh unknown
- 2001-02-28 DE DE60100022T patent/DE60100022T3/de not_active Expired - Fee Related
- 2001-02-28 IT IT2001MI000406A patent/ITMI20010406A1/it unknown
- 2001-03-05 CZ CZ2001808A patent/CZ292077B6/cs not_active IP Right Cessation
- 2001-03-07 AT AT0016601U patent/AT4364U1/de unknown
- 2001-03-09 ES ES200100548A patent/ES2159491B1/es not_active Expired - Fee Related
- 2001-07-26 AU AU2001100197A patent/AU2001100197B4/en not_active Expired
- 2001-09-14 SE SE0103046A patent/SE517136C2/sv not_active IP Right Cessation
2002
- 2002-01-23 NO NO20020356A patent/NO315851B1/no unknown
- 2002-03-12 SE SE0200730A patent/SE526022C2/sv not_active IP Right Cessation
- 2002-09-05 BG BG107065A patent/BG107065A/bg unknown
- 2002-09-05 ZA ZA200207148A patent/ZA200207148B/en unknown
- 2002-09-12 US US10/245,824 patent/US20030078442A1/en not_active Abandoned
2003
- 2003-12-19 US US10/741,553 patent/US20040132808A1/en not_active Abandoned
- 2003-12-30 US US10/750,049 patent/US20040167210A1/en not_active Abandoned
2005
- 2005-03-24 US US11/090,336 patent/US20050165092A1/en not_active Abandoned
- 2005-03-24 US US11/090,337 patent/US20050165244A1/en not_active Abandoned
2006
- 2006-06-20 US US11/425,321 patent/US20060247451A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1227088B1 (en)	2003-09-17
ES2173054T3 (es)	2002-12-16
DK173903B1 (da)	2002-02-11
JP2003527383A (ja)	2003-09-16
AU2001100197A4 (en)	2001-09-20
HU0100531D0 (en)	2001-03-28
GB2357762B (en)	2002-01-30
SK13132002A3 (sk)	2003-01-09
EA200200972A1 (ru)	2003-02-27
GB0102797D0 (en)	2001-03-21
SI1169314T1 (en)	2002-12-31
PT1169314E (pt)	2002-11-29
GB2357762A (en)	2001-07-04
SE526022C2 (sv)	2005-06-14
ES2159491A1 (es)	2001-10-01
US20030078442A1 (en)	2003-04-24
NO20020356D0 (no)	2002-01-23
CN1680350A (zh)	2005-10-12
EP1169314B1 (en)	2002-09-04
CH691537A5 (de)	2001-08-15
AU2001100197B4 (en)	2001-12-06
SE0200730D0 (sv)	2002-03-12
IL158072A0 (en)	2004-03-28
AT4364U1 (de)	2001-06-25
YU68802A (sh)	2005-11-28
EP1169314B2 (en)	2011-06-01
FI20010156A0 (sv)	2001-01-25
FI109022B (sv)	2002-05-15
DK1169314T3 (da)	2002-10-14
DE60100786D1 (de)	2003-10-23
DE60100022T3 (de)	2011-11-17
HUP0100531A2 (hu)	2002-01-28
SI1169314T2 (sl)	2011-08-31
US20060247451A1 (en)	2006-11-02
ITMI20002425A1 (it)	2002-05-09
CN1429220A (zh)	2003-07-09
US20050165244A1 (en)	2005-07-28
ES2159491B1 (es)	2002-05-01
IES20010109A2 (en)	2002-02-20
HRP20020756A2 (en)	2004-12-31
KR20020080486A (ko)	2002-10-23
DE60100022T2 (de)	2003-03-06
FR2806086A1 (fr)	2001-09-14
FR2806086B1 (fr)	2003-05-09
AR029811A1 (es)	2003-07-16
DE10108042A1 (de)	2001-10-18
IT1319645B1 (it)	2003-10-23
US20040167210A1 (en)	2004-08-26
IL147339A0 (en)	2002-08-14
DE60100786T2 (de)	2004-07-15
NO312031B1 (no)	2002-03-04
ZA200207148B (en)	2003-04-23
FI20010225L (sv)	2001-09-14
DE20121240U1 (de)	2002-07-04
ATE223396T1 (de)	2002-09-15
SI1227088T1 (en)	2003-12-31
NL1016435C1 (nl)	2000-11-06
CZ292077B6 (cs)	2003-07-16
AU3725201A (en)	2001-09-13
HU0001581D0 (en)	2000-06-28
SE0103046L (sv)	2001-11-14
IS5841A (is)	2001-09-14
HK1054750A1 (en)	2003-12-12
AU746664B2 (en)	2002-05-02
IL147339A (en)	2004-09-27
ITMI20010406A1 (it)	2002-08-28
FI20010225A0 (sv)	2001-02-07
NO20020356L (no)	2001-09-14
DK1227088T3 (da)	2003-12-22
GR1003796B (el)	2002-02-08
CH691477A5 (de)	2001-07-31
UA74360C2 (uk)	2005-12-15
US20050165092A1 (en)	2005-07-28
CA2360287A1 (en)	2001-09-20
SK285528B6 (sk)	2007-03-01
CN1258530C (zh)	2006-06-07
BR0109373A (pt)	2002-12-24
NL1017413C1 (nl)	2001-09-13
NO20010619D0 (no)	2001-02-06
US20040132808A1 (en)	2004-07-08
PT1227088E (pt)	2003-12-31
CA2411732A1 (en)	2001-09-20
BE1013210A3 (fr)	2001-10-02
CZ2001808A3 (cs)	2002-01-16
DE10164687B4 (de)	2006-04-27
DE1227088T1 (de)	2003-02-06
HUP0100531A3 (en)	2004-04-28
TR200202185T2 (tr)	2002-12-23
PL360158A1 (en)	2004-09-06
SE0103046D0 (sv)	2001-09-14
HU0100450D0 (en)	2001-04-28
US20010031784A1 (en)	2001-10-18
CA2360287C (en)	2003-09-09
DE20007303U1 (de)	2000-07-27
ATE250050T1 (de)	2003-10-15
EP1227088A1 (en)	2002-07-31
DE60100022D1 (de)	2002-10-10
NO315851B1 (no)	2003-11-03
WO2001068627A1 (en)	2001-09-20
BG107065A (bg)	2003-05-30
ES2180471T3 (es)	2004-05-01
EP1169314A1 (en)	2002-01-09
GB0105982D0 (en)	2001-05-02
SE517136C2 (sv)	2002-04-16
ES2173054T1 (es)	2002-10-16
MXPA02008793A (es)	2003-02-12
NO20010619L (no)	2001-09-14
ES2180471T1 (es)	2003-02-16

Legal Events

Date	Code	Title	Description
2009-11-17	NUG	Patent has lapsed

Publication	Publication Date	Title
SE0103046D0 (sv)	2001-09-14	Kristallin bas av citalopram
TW200612195A (en)	2006-04-16	Oxime derivatives and the use therof as latent acids
PT2428519E (pt)	2015-04-29	Processo para preparação de 17-o-vinil-triflatos como intermediários
AR041297A1 (es)	2005-05-11	Derivados de 4-pirrolidino- fenil- bencil eter
ATE452882T1 (de)	2010-01-15	Herstellung von quetiapin
UY27842A1 (es)	2003-12-31	Fluorobenzamidas
DE60306667D1 (de)	2006-08-17	Cefdinir salze als zwischenprodukte
NO20002589D0 (no)	2000-05-19	Bifenylamidinderivater
CO5601030A2 (es)	2006-01-31	Derivados de quinolinona/benzoxazinona y usos de los mismos
AR038624A1 (es)	2005-01-19	Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo
AR027559A1 (es)	2003-04-02	Metodo para la preparacion de citalopram
BR0208812A (pt)	2004-03-09	Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
EA200500133A1 (ru)	2005-08-25	Производные пирролидина в качестве антагонистов окситоцина
AR037005A1 (es)	2004-10-20	Derivados de acidos dimetilfenilaceticos, derivados de piperidina, y proceso para la produccion de derivados de piperidina.
HRP20050424A2 (en)	2006-08-31	Process for making risperidone and intermediates thereof
DE60101786D1 (de)	2004-02-19	Verfahren zur herstellung von citalopram
EP1148783A4 (en)	2003-05-21	CONVERSION OF COX INHIBITING, NON COX-2 SELECTIVE INHIBITORS TO DERIVATIVES OF COX-2 SELECTIVE INHIBITORS
AR029893A1 (es)	2003-07-23	Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica
NO20032314D0 (no)	2003-05-22	Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
AR015924A1 (es)	2001-05-30	Procedimiento para la preparacion de derivados aminicos de alquiloxi-furanona,compuestos procedentes de este procedimiento, utilizacion de estos compuestosy compuestos intermediarios
DE602004015310D1 (de)	2008-09-04	Verfahren zur herstellung von mycophenolatmofetil
NO330989B1 (no)	2011-08-29	Nye piperazinderivater, fremgangsmater for fremstilling av slike og deres anvendelse som syntesemellomprodukter.
NO20053712L (no)	2005-08-01	Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
DE60137352D1 (de)	2009-02-26	Nsalze, verfahren zur herstellung von beiden und ihre verwendung
PT1423385E (pt)	2008-09-24	Intermediários para preparar conjugados inibidores da neuraminidase